Status:
TERMINATED
Building Self-regulation Capacity in AA T2DM Women: Feasibility of EMI
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Chicago
Conditions:
Type 2 Diabetes
Self-regulation
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
In African-Americans, the incidence of type 2 diabetes (T2DM) is \~14%. Adherence to crucial diabetes self-management (DSM) behaviors, such as engaging in physical activity (PA) is dangerously low amo...
Detailed Description
All visits will take place at the University of Illinois at Chicago (UIC) College of Nursing Clinical Diabetes and Exercise Laboratory. At time 1 (T1), participants will complete baseline assessments....
Eligibility Criteria
Inclusion
- African American/Black female
- History of T2DM \> 1 year
- Age \> 40 years of age
- On non-insulin anti-diabetic therapy or diet-controlled
- Smartphone owner
Exclusion
- Women with type 1 diabetes
- Women using insulin
- Any condition that would prohibit the ability to walk for 15-30 minutes or participate in light to moderate physical activity
- Low cognitive function (Mini-cog \<3)
- A1c \> 10%
Key Trial Info
Start Date :
September 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04083248
Start Date
September 20 2019
End Date
July 31 2020
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago, College of Nursing
Chicago, Illinois, United States, 60612